Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms

A Inserra, D De Gregorio, G Gobbi - Pharmacological Reviews, 2021 - ASPET
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Psychedelics

DE Nichols - Pharmacological reviews, 2016 - ASPET
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter
perception and mood and affect numerous cognitive processes. They are generally …

[HTML][HTML] The effects of serotonin in immune cells

N Herr, C Bode, D Duerschmied - Frontiers in cardiovascular …, 2017 - frontiersin.org
Serotonin [5-hydroxytryptamine (5-HT)] plays an important role in many organs as a
peripheral hormone. Most of the body's serotonin is circulating in the bloodstream …

Psychedelics as medicines: an emerging new paradigm

DE Nichols, MW Johnson… - Clinical Pharmacology & …, 2017 - Wiley Online Library
Scientific interest in serotonergic psychedelics (eg, psilocybin and LSD; 5‐HT2A receptor
agonists) has dramatically increased within the last decade. Clinical studies administering …

[HTML][HTML] Critical neurotransmitters in the neuroimmune network

TW Hodo, MTP De Aquino, A Shimamoto… - Frontiers in …, 2020 - frontiersin.org
Immune cells rely on cell-cell communication to specify and fine-tune their responses. They
express an extensive network of cell communication modes, including a vast repertoire of …

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

KPC Kuypers, L Ng, D Erritzoe… - Journal of …, 2019 - journals.sagepub.com
Background: In the past few years, the issue of 'microdosing'psychedelics has been openly
discussed in the public arena where claims have been made about their positive effect on …

Psychedelics as anti-inflammatory agents

TW Flanagan, CD Nichols - International Review of Psychiatry, 2018 - Taylor & Francis
Abstract Serotonin (5-hydroxytryptamine, 5-HT) 2A receptor agonists have recently emerged
as promising new treatment options for a variety of disorders. The recent success of these …

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

[HTML][HTML] Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

NL Mason, A Szabo, KPC Kuypers, PA Mallaroni… - Brain, Behavior, and …, 2023 - Elsevier
Patients characterized by stress-related disorders such as depression display elevated
circulating concentrations of pro-inflammatory cytokines and a hyperactive HPA axis …

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

A Garcia-Romeu, WA Richards - International Review of Psychiatry, 2018 - Taylor & Francis
Humans have used serotonergic hallucinogens (ie psychedelics) for spiritual, ceremonial,
and recreational purposes for thousands of years, but their administration as part of a …